Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17020
Country/Region: South Africa
Year: 2016
Main Partner: Anova Health Institute
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $2,269,511 Additional Pipeline Funding: $4,152,799

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $449,361
Care: TB/HIV (HVTB) $374,533
Care: Pediatric Care and Support (PDCS) $132,302
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $114,603
Treatment: Adult Treatment (HTXS) $1,066,410
Treatment: Pediatric Treatment (PDTX) $132,302
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 2,751
HTS_TST Age/sex: 1-9 2017 27,309
HTS_TST Age/sex: 10-14 Female 2017 7,519
HTS_TST Age/sex: 10-14 Male 2017 7,537
HTS_TST Age/sex: 15-19 Female 2017 7,296
HTS_TST Age/sex: 15-19 Male 2017 7,112
HTS_TST Age/sex: 20-24 Female 2017 6,883
HTS_TST Age/sex: 20-24 Male 2017 7,317
HTS_TST Age/sex: 25-49 Female 2017 37,319
HTS_TST Age/sex: 25-49 Male 2017 38,544
HTS_TST Age/sex: 50+ Female 2017 17,922
HTS_TST Age/sex: 50+ Male 2017 14,263
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 7,090
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 7,086
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 139,488
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 90,620
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 244,285
HTS_TST Service Delivery Point (Facility): Index testing 2017 3,491
HTS_TST Service Delivery Point (Facility): Inpatient 2017 3,897
HTS_TST Service Delivery Point (Facility): Pediatric 2017 16,096
HTS_TST Service Delivery Point (Facility): PMTCT 2017 42,133
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 5,241
HTS_TST Service Delivery Point (Facility): VCT 2017 173,431
HTS_TST Sum of Age/Sex disaggregates 2017 151,712
HTS_TST Sum of Aggregated Age/Sex <15 2017 14,176
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 230,108
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 244,284
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 1,443
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 1,475
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 1,397
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 1,395
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 1,316
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 1,362
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 7,159
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 7,626
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 3,455
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 2,755
HTS_TST_POS Test Result by Age: Positive: <1 2017 525
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 5,244
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 174
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 170
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 23,883
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 15,608
PMTCT_ART Already on ART at beginning of current pregnancy 2017 5,855
PMTCT_ART Already on ART at beginning of current pregnancy 2017 7
PMTCT_ART New on ART 2017 10,864
PMTCT_ART New on ART 2017 18
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 71,367
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 16,616
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 207
PMTCT_EID Sum of Infant Age disaggregates 2017 16,616
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 10
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 2,347
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 11,873
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 38,425
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 237
PMTCT_STAT By: Known positives at entry 2017 34,862
PMTCT_STAT By: Number of new positives identified 2017 36,504
PMTCT_STAT Number of new ANC and L&D clients 2017 73,308
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 71,367
PMTCT_STAT Required only for DREAMS countries - By known positives: 15-19 2017 1,063
PMTCT_STAT Required only for DREAMS countries - By known positives: 20-24 2017 5,363
PMTCT_STAT Required only for DREAMS countries - By known positives: 25-49 2017 17,348
PMTCT_STAT Required only for DREAMS countries - By known positives: 50+ 2017 108
PMTCT_STAT Required only for DREAMS countries - By new positives: <15 2017 2
PMTCT_STAT Required only for DREAMS countries - By new positives: 15-19 2017 1,290
PMTCT_STAT Required only for DREAMS countries - By new positives: 20-24 2017 6,505
PMTCT_STAT Required only for DREAMS countries - By new positives: 25-49 2017 21,078
PMTCT_STAT Required only for DREAMS countries - By new positives: 50+ 2017 479
PMTCT_STAT Sum of Positives Status disaggregates 2017 71,366
PMTCT_STAT_den Required only for DREAMS countries - Denominator: <15 2017 8
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 15-19 2017 2,412
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 20-24 2017 12,227
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 25-49 2017 39,562
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 50+ 2017 263
PP_PREV Aggregated Age/sex: <15 Female 2017 3,438
PP_PREV Aggregated Age/sex: <15 Male 2017 3,438
PP_PREV Aggregated Age/sex: 15+ Female 2017 13,747
PP_PREV Aggregated Age/sex: 15+ Male 2017 13,747
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 34,369
PP_PREV Total number of people in the target population 2017 702,776
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 468
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2,506
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1,731
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4,336
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 7,422
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 9,048
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 9,643
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 1,026
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 8,911
TB_SCREENDX Screen Results: Screened Positive for TB 2017 9,462
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 15,710
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 17,215
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 117,258
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 154,543
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 309,201
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 668
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 4,993
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 682
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 6,486
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 12,840
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 13,478
TX_CURR Age/Sex: <1 2017 681
TX_CURR Age/Sex: 1-9 2017 3,601
TX_CURR Age/Sex: 10-14 Female 2017 1,267
TX_CURR Age/Sex: 10-14 Male 2017 1,197
TX_CURR Age/Sex: 15-19 Female 2017 2,549
TX_CURR Age/Sex: 15-19 Male 2017 1,131
TX_CURR Age/Sex: 20-24 Female 2017 8,750
TX_CURR Age/Sex: 20-24 Male 2017 1,662
TX_CURR Age/Sex: 25-49 Female 2017 111,173
TX_CURR Age/Sex: 25-49 Male 2017 50,497
TX_CURR Age/Sex: 50+ Female 2017 13,898
TX_CURR Age/Sex: 50+ Male 2017 17,874
TX_CURR Aggregated Age/Sex: <15 Female 2017 8,298
TX_CURR Aggregated Age/Sex: <15 Male 2017 8,326
TX_CURR Aggregated Age/Sex: 15+ Female 2017 162,654
TX_CURR Aggregated Age/Sex: 15+ Male 2017 108,131
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 287,389
TX_CURR Sum of Age/Sex disaggregations 2017 3,680
TX_CURR Sum of Aggregated Age/Sex <15 2017 16,624
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 270,785
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 287,409
TX_NEW Aggregated Grouping by Age: <1 2017 48
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 1,807
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 1,770
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 41,027
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 27,322
TX_NEW By Age/Sex: 1-9 2017 773
TX_NEW By Age/Sex: 10-14 Female 2017 153
TX_NEW By Age/Sex: 10-14 Male 2017 155
TX_NEW By Age/Sex: 15-19 Female 2017 679
TX_NEW By Age/Sex: 15-19 Male 2017 157
TX_NEW By Age/Sex: 20-24 Female 2017 3,844
TX_NEW By Age/Sex: 20-24 Male 2017 382
TX_NEW By Age/Sex: 25-49 Female 2017 30,520
TX_NEW By Age/Sex: 25-49 Male 2017 14,016
TX_NEW By Age/Sex: 50+ Female 2017 3,400
TX_NEW By Age/Sex: 50+ Male 2017 2,998
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 71,930
TX_NEW Sum of Age/Sex disaggregates 2017 56,304
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 71,926
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 239,363
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 232,788
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 6,762
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 6,734
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 131,576
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 87,715
TX_PVLS Numerator: Indication: Routine 2017 232,788
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 5,034
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 5,035
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 98,101
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 65,398
TX_PVLS_den Denominator: Indication: Routine 2017 232,788
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 329
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,741
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 612
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 555
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,229
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 546
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,258
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 800
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 53,653
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 24,373
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6,714
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8,635
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,955
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,915
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 96,259
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 64,358
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 172,174
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 179,075
TX_RET_den Age/Sex: <1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 353
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,848
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 650
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 622
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,312
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 582
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,523
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 856
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 57,068
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 25,928
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 7,131
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9,186
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 789
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 760
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 72,700
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 38,314
Cross Cutting Budget Categories and Known Amounts Total: $220,000
Motor Vehicles: Purchased $120,000
Motor Vehicles: Leased $100,000